Effects of ramosetron orally disintegrating tablets on the prophylaxis of post-discharge nausea and/or vomiting in female patients undergoing day surgery under general anesthesia: a randomized controlled trial

ConclusionRamosetron ODT reduces the incidence and severity of postoperative nausea after discharge during the first 24 h and may be a valuable option for the prevention of PDNV in female patients after day surgery under general anesthesia.Trial registrationClinicalTrials.gov,NCT04297293. Registered on 05 March 2020
Source: Perioperative Medicine - Category: Surgery Source Type: research